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OBJECTIVES We sought to assess whether there were differences, relative to racial ethnicity, in coronary
revascularization recommendations made by a panel that had no knowledge of the patients’
ethnicity.
BACKGROUND Coronary revascularization is employed less frequently in African American than in white
patients. It is unclear whether this utilization pattern is driven by clinical differences between
the two populations or by nonclinical factors.
METHODS Data were reviewed from 938 (26.5% African American, 73.5% white) consecutive cardiac
catheterizations done between 1993 and 1995. Revascularization recommendations were
made by cardiologists and cardiothoracic surgeons provided with the patients’ clinical and
angiographic data, but without knowledge of their ethnicity. Revascularization recommen-
dations were compared between African American and white patients and correlated with
clinical characteristics.
RESULTS No difference was noted in the percentage of African American and white patients
recommended for revascularization, without reference to whether the recommendation was
for percutaneous transluminal coronary angioplasty (PTCA) or for coronary artery bypass
graft surgery (CABG) 40 vs. 46%, p 5 NS). African Americans were recommended more
frequently for PTCA (22 vs. 18%, p 5 NS), whereas CABG was recommended for more
white patients (28 vs. 18%, p 5 0.002). Significantly fewer African Americans had disease in
the left main or left anterior descending coronary artery or in multiple arteries. After adjusting
for age, co-morbidity, left ventricular dysfunction and the extent of coronary disease, African
Americans were more likely to have a recommendation for PTCA (odds ratio [OR] 1.42,
95% confidence interval [CI] 0.96 to 2.11, p 5 0.08) and less likely to have a recommendation
for CABG (OR 0.59, 95% CI 0.37 to 0.94, p 5 0.02).
CONCLUSIONS This study suggests that when only clinical factors are considered, the rates of recommen-
dations for revascularization will be similar for white and African American patients; but the
type of revascularization procedure may differ by ethnicity and may depend, in part, on clinical
factors. (J Am Coll Cardiol 2001;38:698–704) © 2001 by the American College of
Cardiology
Although coronary artery disease (CAD) is the leading
cause of death among both African Americans and white
Americans (1–4), several studies have reported a racial
discrepancy in the use of revascularization procedures (i.e.,
coronary artery bypass graft surgery [CABG] and percuta-
neous transluminal coronary angioplasty [PTCA]) as treat-
ments for this disorder (5–14). These observations have
been reported in clinical trials of revascularization
(7,8,15,16), in surveys of data bases consisting of Medicare
cohorts (17), Veterans Affairs Medical Center cohorts
(9,10) and single-center cohorts (18) and in state-based
registries (19). Although some studies show that African
Americans with CAD do as well as whites (10,15), despite
the difference in procedure utilization, other studies report a
worse prognosis in African Americans with cardiovascular
disease (8,12,18). Recent U.S. surveys continue to indicate a
40% to 85% higher rate of heart disease mortality in African
Americans compared with whites (2–4,18,20,21). Thus, the
lower utilization of revascularization procedures may con-
tribute to the poorer outcome reported in African Ameri-
cans with CAD (1,3,4,18).
Patient ethnicity as an independent and important deter-
minant of treatment decisions for CAD has been difficult to
evaluate. Attempts to statistically isolate the biologic and
nonbiologic factors associated with ethnicity, which might
guide physician treatment choices, have met with limited
success. Separation of medical factors that determine pro-
cedure utilization, such as natural history, the distribution of
CAD and the incidence of comorbidities, from nonmedical
factors, such as the patients’ socioeconomic status, the level
of expertise of the physician caring for the patient, access of
particular groups of patients to subspecialists, differences in
the patients’ acceptance of provider recommendations and
differences in the physicians’ perception of the patients’ need
for procedures, is problematic (22). Currently, data measur-
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ing the relative importance of each of these factors in
determining the racial variance in the utilization of revas-
cularization procedures are lacking.
Analysis of data on health care services utilization from
Medicare cohorts (15) represents one attempt to evaluate
the role of racial variations in the utilization of revascular-
ization procedures. There are considerable differences, how-
ever, in economic resources among Medicare recipients, so
that a single health care payer does not guarantee equal
access to procedures. Procedure utilization has also been
examined in cohorts from Veterans Affairs hospitals, pop-
ulations wherein economic differences among patients are
diminished, and the presence of salaried physicians elimi-
nates financial advantages to physicians who recommend or
withhold specialized procedures. It is noteworthy that sev-
eral surveys in Veterans Affairs hospital populations have
reported differences in procedure utilization, according to
race, that parallel those in the general population (9–11).
Although registry-based reports suggest that race may
importantly influence a patient’s likelihood of undergoing
revascularization procedures, these surveys were not able to
evaluate the contribution that ethnic differences in coronary
disease distribution, co-morbidity and nonmedical factors
make to physician decision-making.
To assess whether ethnicity may be an independent,
important factor contributing to differences in procedure
utilization, it is essential to critically examine the individual
steps leading to procedure utilization in selected populations
in which the decision-making process can be closely corre-
lated with clinical factors and in which socioeconomic
differences among patients are smaller. At the Cleveland
Veterans Affairs Medical Center, it has been the practice to
review all coronary angiograms weekly by a committee
composed of experienced clinical cardiologists, interven-
tional cardiologists and cardiothoracic surgeons. Although
the clinical symptoms and presentation are coupled with
angiographic and physiologic data to arrive at a treatment
recommendation, the patient’s ethnicity is generally not
presented. Thus, we had the opportunity to evaluate ethnic
variability in provider treatment recommendations in a
setting where the effects of socioeconomic status and phy-
sician financial incentives were minimal and physician
knowledge of the patients’ ethnicity was extremely limited.
To evaluate differences, by race, in procedure utilization
at a key point in treatment selection (procedure recommen-
dation after angiography), we reviewed 1,022 consecutive
cardiac catheterizations performed between 1993 and 1995
for treatment recommendations made by this protocol, and
we compared the revascularization recommendations in
African American and white patients. Furthermore, to
understand the possible role of anatomic and physiologic
factors in the decision-making process, we compared the
extent and severity of coronary stenoses, left ventricular
(LV) function and comorbidity between the two groups.
METHODS
Study design and patients. The sample was drawn from
1,022 consecutive cardiac catheterizations from 1993 to
1995. Eighty-four patients undergoing repeat catheteriza-
tion during the study period were excluded from consider-
ation, because the procedure was done to evaluate valvular
heart disease, myocardial or pericardial disease. Patients
undergoing repeat catheterization (n 5 56) in this interval
were included if the catheterization resulted in a new
treatment decision. A final cohort of 938 catheterizations in
882 patients forms the data base. Clinical data collected
included that accessible from the Decentralized Hospital
Computer Program data base, as well as data from detailed
angiographic reports. Coronary anatomy (location, number
and extent of coronary stenoses), LV function, as assessed by
either angiography, gated radionuclide ventriculography or
echocardiography, and comorbidity were noted for each
patient. Data requiring a patient interview or chart review,
such as severity of angina or symptoms of congestive heart
failure, were not available for this retrospective study.
Additional details of coronary anatomy requiring angio-
graphic review, such as diffuseness of the disease and
adequacy of target vessels, were also not collected.
Classification of CAD was based on visual interpretation
using standard criteria (23,24). Grading of the severity of
CAD was in accordance with the American Heart Associ-
ation’s Ad Hoc Committee for Grading of Coronary Artery
Disease (25). The degree of stenosis was quantitated from
the moving cineangiogram by visual estimation of the
percent reduction in diameter relative to the caliber of the
apparently nondiseased adjacent segments, with the range of
lumen diameter reductions from 0% (normal coronary
segment) to 100% (completely occluded vessel). When left
main coronary artery (LMCA) disease was noted, measure-
ments were made with handheld calipers and a magnifying
scale. A lumen diameter reduction of $50% at the LMCA
(equal to a 75% reduction in cross-sectional area) was
considered significant. In CAD other than that in the
LMCA, stenoses .70% were significant and considered
proximal if they were located in the right coronary artery
before the acute marginal branch, in the left anterior
descending coronary artery (LAD) before the first septal
perforator branch or in the left circumflex artery before the
obtuse marginal branch. Significant lesions in the major
Abbreviations and Acronyms
CABG 5 coronary artery bypass graft surgery
CAD 5 coronary artery disease
CI 5 confidence interval
LAD 5 left anterior descending coronary artery
LMCA 5 left main coronary artery
LV 5 left ventricle or ventricular
OR 5 odds ratio
PTCA 5 percutaneous transluminal coronary
angioplasty
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branches of the left coronary artery system (i.e., anterior
descending, diagonal, circumflex and obtuse marginal arter-
ies) were measured and recorded.
Left ventricular function was measured by LV angiogra-
phy in the majority of cases (n 5 682). Calculation of
ejection fraction by LV angiography was done using single-
plane cine left ventriculography in the right anterior oblique
projection using the area-length method. Cine angiographic
data were processed by Trinity Computing systems (Green-
way Plaza, Houston, Texas) and LV ejection fraction $50%
was interpreted as normal, 35% to 50% as mild LV systolic
dysfunction, 20% to 35% as moderate LV systolic dysfunc-
tion and ,20% as severe LV systolic dysfunction. In 123
patients in whom a ventriculogram was not obtained,
functional evaluation of the LV was determined from
two-dimensional echocardiography or radionuclide ven-
triculography. The same quantitative criteria were used to
describe LV function on a gated blood-pool study. Echo-
cardiography of LV function was assessed semiquantita-
tively by experienced echocardiographers and was described
as normal or mild, moderate or severe LV dysfunction.
Estimation of ejection fraction by this echocardiographic
method has been shown to be accurate and reliable when
assessed by experienced echocardiographers (26,27).
Comorbidity was defined in the following manner: 1) the
presence of clinically significant renal disease was defined by
serum creatinine $2.0 mg/dl; 2) significant pulmonary
disease was identified by pulmonary function tests (when
available) and/or by the presence of bronchodilators or
methylxanthines on the patient’s computerized medication
profile; and 3) diabetes was identified by the presence of
either insulin or oral hypoglycemic agents on the patient’s
medication profile. Although hypertension is clearly more
prevalent in African American than white patients, this
variable (in contrast to the other co-morbidities measured)
was not specifically noted, because its presence or absence
neither contributes to a decision to revascularize nor influ-
ences the choice of the procedure.
All angiographic cases were discussed weekly in a cardiac
catheterization conference by a committee consisting of an
interventional cardiologist, a cardiothoracic surgeon and a
clinical cardiologist. The committee reviewed all angio-
graphic studies from the previous week, including those
patients for whom urgent or emergent treatment had been
required. Data presented for each patient were strictly
limited to clinical factors that might influence the treatment
choice. For this reason, the patients’ ethnicity was not
presented. The recommendation of this committee was
considered as the final treatment recommendation.
Decisions regarding the mode of therapy were based on
clinical and angiographic variables. Angiographic variables
included the number and location of diseased vessels, the
presence or absence of LMCA disease, the extent of disease
in the distal vessel, LV systolic function and regional
contractile function of the territory supplied by the diseased
vessel. The clinical variables considered included the pres-
ence or absence of unstable angina, the severity of angina in
patients with stable angina treated with medication, objec-
tive evidence of ischemia on radionuclide stress perfusion
imaging or stress echocardiography and the presence of
diabetes mellitus, renal or pulmonary disease. Patients with
significant atherosclerotic disease in the LMCA and in all
three major coronary arteries were referred for CABG.
Most patients with double-vessel disease involving the
proximal LAD and proximal right coronary arteries were
also referred for CABG. Patients with single-vessel disease
technically amenable to a coronary intervention and with
objective evidence of ischemia were generally referred for a
catheter-based intervention. Although patients with two-
vessel disease not involving the LAD were often referred for
PTCA, many also were referred for either medical manage-
ment or CABG depending on the particular anatomic and
physiologic findings. These treatment recommendations are
consistent with those described for the Coronary Artery
Surgery Study (22,23).
Statistical analysis. Statistical analysis involved three steps.
First, the demographic and clinical characteristics of white
and African American patients undergoing left heart cath-
eterization were compared by using the chi-square test or
the Wilcoxon signed-rank test. Second, treatment recom-
mendations in white and African American patients with
significant stenosis in one or more coronary arteries were
compared by using the chi-square test. Analyses compared
recommendations for CABG, PTCA and revascularization
by either CABG or PTCA. Third, to adjust for the
potential confounding influence of demographic and clinical
factors in recommendations, additional logistic regression
analyses were performed. Separate analyses were performed
for CABG and PTCA. Independent variables in these
analyses included age, African American ethnicity, the
presence of specific comorbid disease (diabetes, pulmonary
or renal disease), LV dysfunction (classified as mild, mod-
erate or severe), the number of coronary arteries with
significant stenosis and involvement of specific arteries. The
multivariate odds ratio (OR) associated with African Amer-
Table 1. Clinical Characteristics of Patients
Undergoing Angiography
African Americans
(n 5 249) (26.5%)
Whites
(n 5 689) (73.5%) p Value
Age (yrs) 62.0 6 10.0 62.4 6 9.6 NS
Men 98% 97% NS
Diabetes 35% 34% NS
COPD 27% 27% NS
Renal disease 11% 7% 0.04
LV dysfunction* 47% 34% 0.01
Previous CABG 11% 21% , 0.001
*Data are based on 215 African American and 590 white patients in whom left
ventricular function was assessed by angiography, radionuclide ventriculography or
echocardiography. Data are presented as the mean value 6 SD or percentage of
patients.
CABG 5 coronary artery bypass graft surgery; COPD 5 chronic obstructive
pulmonary disease; LV 5 left ventricular; NS 5 not significant.
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ican ethnicity was used to estimate the relative rates of
CABG and PTCA in African American and white patients.
RESULTS
The clinical characteristics of the study cohort are presented in
Table 1. African American patients made up 27% of the study
group and constitute ;30% of the population of the Cleveland
Veterans Affairs Medical Center. The patients’ mean age did
not differ between the two groups, even when subdivided into
three categories (age ,65 years: 55 vs. 51%; 65 to 75 years: 39
vs. 43%; and .75 years: 7 vs. 5.8% for African Americans vs.
whites, respectively). The percentages of male patients, those
with diabetes mellitus or with chronic obstructive pulmonary
disease were not different between the two groups. There were
several noteworthy clinical differences. A somewhat higher
proportion of African Americans had renal disease (11 vs. 7%,
p 5 0.04). More African Americans than whites had LV
dysfunction (47 vs. 34%, p , 0.01), whereas more whites than
African Americans had undergone previous CABG (21 vs.
11%, p , 0.001). Recommendations for revascularization
procedures in African American and white patients are shown
in Figure 1. The percentages of patients with coronary stenoses
recommended for any revascularization procedure (either
PTCA or CABG) were similar between African American
and white patients (40 vs. 46%, p 5 0.1) (Fig. 1A). By
univariate analysis, more white than African American patients
were recommended for CABG (28 vs. 18%, p 5 0.002) (Fig.
1B), whereas more African American than white patients were
recommended for PTCA (22 vs. 18%, p 5 0.2) (Fig. 1C).
Additional stratified analysis examined treatment recommen-
dations in patients with significant stenosis of one, two or three
or more coronary arteries (Table 2). Importantly, no significant
differences in treatment recommendation patterns, in terms of
race, were observed when patients were stratified by race and
number of significantly stenosed coronary arteries.
When the numbers of coronary arteries with significant
stenoses were compared in terms of race, African Americans
were more likely than white patients to have zero, one or
two coronary arteries with significant stenosis, whereas
more white patients had three or more stenosed arteries
(Fig. 2A). No significant coronary disease was observed in
72 African Americans (28%) and in 149 white patients
(21%; p 5 0.02). A comparison of the distribution of
coronary stenoses in the two racial groups also revealed
important differences (Fig. 2B). Fewer African American
patients had LMCA stenosis (6 vs. 11%, p , 0.01), LAD
stenosis (44 vs. 59%, p , 0.001) and right coronary artery
stenosis (50 vs. 58%; p 5 0.01). The percentage of patients
with left circumflex, obtuse marginal or diagonal coronary
artery stenoses did not differ between the two groups.
Finally, using logistic regression analysis, African Amer-
ican and white patients with stenosis of one or more arteries
were compared for differences in recommendations for
CABG and PTCA after controlling for the influence of age,
co-morbidity, location and number of diseased coronary
arteries, LV function and previous CABG. African Amer-
icans still tended to be more likely to receive PTCA (OR
1.42, 95% confidence interval [CI] 0.96 to 2.11, p 5 0.08)
and significantly less likely to receive CABG (OR 0.59, 95%
CI 0.37 to 0.94, p 5 0.02). A slightly but not significantly
higher percentage of African American (46%) than white
(39%) patients underwent the recommended procedure at
the Cleveland Veterans Affairs Medical Center within 90
days of catheterization.
DISCUSSION
Recent reports demonstrate a substantially lower utilization
rate of coronary revascularization procedures in African
American than in white patients, with limited data to
elucidate the reasons for this difference. Our study focused
on one of the key steps in treatment selection—namely, the
treatment recommendation after angiography—and related
revascularization procedure recommendations to selected
angiographic and clinical findings. Data presented in this
Figure 1. (A) The percentage of African American and white patients
recommended for revascularization by either PTCA or CABG. (B)
Percentage of patients referred for CABG. (C) Percentage of patients
referred for PTCA.
Table 2. Rates of Revascularization Procedures by Numbers of Stenosed Vessels and Ethnicity
Procedure















(n 5 309) p Value
PTCA 32% 24% 0.3 43% 31% 0.1 22% 20% 0.7
CABG 4% 9% 0.3 14% 25% 0.1 44% 48% 0.6
Either 36% 32% 0.6 53% 55% 0.8 66% 67% 0.9
Data are presented as the percentage of patients.
CABG 5 coronary artery bypass graft surgery; PTCA 5 percutaneous transluminal coronary angioplasty.
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study suggest that when recommendations for revascular-
ization procedures are driven by clinical factors, the racial
difference in the rates of revascularization become greatly
diminished. In addition, the study suggests that there may
be clinical explanations for the racial differences in the
choice of the revascularization procedure.
The recommendation for CABG or PTCA after cardiac
catheterization was compared in African American and
white patients, by using a protocol in which revasculariza-
tion recommendations were made on the basis of angio-
graphic findings by a panel generally unaware of patient
race. Although absolute blinding of the panel to patient race
could not be assured, patient ethnicity was rarely presented
due to the structure of the conference. Importantly, in
contrast to previous reports in the published data, when
referral for a revascularization procedure was made by the
protocol described, there was no difference between the two
groups in the percentage of patients referred for revascular-
ization by any procedure. By univariate analysis, CABG was
significantly more likely to be recommended for white
patients, and PTCA was marginally more likely to be
recommended for African American patients in our sample.
Multivariate regression analysis adjusting for age, co-
morbidity, location and number of coronary stenoses, LV
function and previous CABG revealed that white patients
were still more likely to undergo CABG and African
American patients were slightly but not significantly more
likely to undergo PTCA. However, when the two groups
were stratified simply by the number of vessels and proce-
dure (Table 2), no difference in procedure utilization by the
number of involved vessels was identified. Differences in
coronary anatomic features and LV function between the
two ethnic groups (e.g., significantly lower incidence of
LMCA, LAD and three-vessel CAD in African American
patients) could account for the differences in the choice of
PTCA versus CABG that remained in our cohort. In
addition, factors such as target-vessel morphology (i.e.,
diffuse vs. focal disease), the presence and severity of angina
and heart failure symptoms, which were not included in the
regression analysis, may be important.
Ethnic patterns of coronary revascularization. Although
the recommendation for treatment is different from utiliza-
tion, it is a key step in treatment utilization. Only one
previous report specifically addressed racial differences in
physicians’ recommendation for CABG, and thus could be
compared with our study (28). Maynard et al. reported that
46.5% of African American patients, compared with 59.4%
of white patients, were recommended for CABG. This
highly significant difference paralleled the observed differ-
ence in procedure utilization in their cohort. Importantly,
the investigators specifically noted that the clinical and
angiographic characteristics of the two groups were not
sufficiently different to account for the difference in treat-
ment recommendation (28), but no details of the recom-
mendation process were provided.
A review of Medicare and Veterans Affairs data bases
(5,9,17) has found significantly greater utilization of CABG
and PTCA in white than in African American patients.
When Medicare patients were stratified by race and income
to adjust for differences in socioeconomic status (5), the
Figure 2. (A) The percentage of African American and white patients with significant stenosis in zero, one, two or three or more coronary arteries. (B)
The distribution of coronary artery stenoses in African American and white patients. LAD 5 left anterior descending coronary artery; Diag 5 diagonal
coronary artery; LCx 5 left circumflex coronary artery; OM 5 obtuse marginal artery; RCA 5 right coronary artery.
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racial difference in procedure utilization persisted across all
income ranges. When cardiac catheterization and revascu-
larization rates were compared in African American and
white veterans after an acute myocardial infarction (10),
African Americans were significantly less likely to undergo
cardiac catheterization, PTCA or CABG. Although these
registry studies provide important information on the rates
of procedure utilization, factors guiding utilization were not
examined.
Two studies in which patients were stratified by race and
disease severity (6,18) reported that African Americans were
less likely to undergo CABG at all levels of disease severity,
including LMCA disease (6). Of note, the outcome of
African American patients was significantly poorer (18). In
these and other cohorts (7,15), investigators noted a lesser
prevalence of LMCA and three-vessel coronary disease in
African Americans.
The contrast between these previously reported patterns
of revascularization referral and procedure utilization and
the results of our study suggests that race may be an
important independent factor for physicians making treat-
ment decisions.
Factors contributing to procedure use. We recognize
that the etiology of the racial difference in procedure
utilization is both multifactorial and complex. Patient-based
biologic factors may contribute to ethnic variation in utili-
zation patterns. Data from several studies have suggested
that differences exist in the anatomic distribution or sever-
ity of CAD between African Americans and whites
(3,7,12,15,16). Although many studies have involved large
numbers of patients (7,15,16), the percentage of African
Americans included in these studies was quite small, leaving
open the possibility that the African American patients in
these cohorts consisted of selected subgroups not represen-
tative of the African American population as a whole.
Importantly, not one study supported the concept that lesser
procedure utilization in African Americans could be exclu-
sively attributed to lesser disease burden.
Patient socioeconomic status and culturally based deter-
minants of physician decision-making, such as the level of
expertise of the physician caring for the patient (specialist vs.
generalist), access of particular groups of patients to differ-
ent levels of physician expertise, the physician’s perception
of the patient, as well as cultural differences that interfere
with the patient’s acceptance of physician recommendations
(23,28), may also have an impact on treatment recommen-
dations. The role played by each of these factors requires
separate study.
Study limitations. Although the results of this retrospec-
tive review are highly provocative, there are some study
limitations requiring further evaluation of this model. It
must be emphasized that our study does not examine how
patients are referred for cardiac catheterization—another
crucial step in the decision process leading to revasculariza-
tion. We were able to examine the revascularization decision
process only after catheterization. However, other studies
scrutinizing patient management after catheterization have
found different patterns of procedure utilization (6,9). Other
variables, such as the appearance of target vessels, collater-
alization, the presence of diffuse as opposed to focal lesions,
the severity of angina and symptoms of congestive heart
failure, which might influence treatment decisions, could
not be readily examined in this review. Another study
limitation was the inability to assess patients’ reception of
the treatment recommendation. Although a similar propor-
tion of African American and white patients (46 vs. 39%,
p 5 NS) underwent the recommended procedure at this
Veterans Affairs Medical Center, we have no information
on the patients who did not. Finally, this study was not a
prospective study with strict physician blinding to patient
race; rather, it was a retrospective study taking advantage of
a decision process in which patient ethnicity was generally
unknown to those making the decision regarding procedure
referral. Nonetheless, our findings that the overall revascu-
larization rate did not differ between racial groups and that
differences in treatment did not exist when patients with
one-, two- or three-vessel disease were compared, in con-
trast to other reports in the published data, suggests a
critical need for additional research on the clinical and
psychosocial factors directing physician utilization of spe-
cific cardiovascular procedures.
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